146 related articles for article (PubMed ID: 31446026)
1. Confocal Raman spectroscopy: Evaluation of a non-invasive technique for the detection of topically applied ketorolac tromethamine in vitro and in vivo.
Bertens CJF; Zhang S; Erckens RJ; van den Biggelaar FJHM; Berendschot TTJM; Webers CAB; Nuijts RMMA; Gijs M
Int J Pharm; 2019 Oct; 570():118641. PubMed ID: 31446026
[TBL] [Abstract][Full Text] [Related]
2.
Zhang S; Bertens CJF; Erckens RJ; van den Biggelaar FJHM; Berendschot TTJM; Webers CAB; Nuijts RMMA; Gijs M
Data Brief; 2019 Dec; 27():104694. PubMed ID: 31720341
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of low concentrations of ketorolac tromethamine in animal models of ocular inflammation.
Waterbury LD; Flach AJ
J Ocul Pharmacol Ther; 2004 Aug; 20(4):345-52. PubMed ID: 15321029
[TBL] [Abstract][Full Text] [Related]
4. Ocular bioavailability and tissue distribution of [14C]ketorolac tromethamine in rabbits.
Ling TL; Combs DL
J Pharm Sci; 1987 Apr; 76(4):289-94. PubMed ID: 3598886
[TBL] [Abstract][Full Text] [Related]
5. Effect of benzalkonium chloride/EDTA on the ocular bioavailability of ketorolac tromethamine following ocular instillation to normal and de-epithelialized corneas of rabbits.
Madhu C; Rix PJ; Shackleton MJ; Nguyen TG; Tang-Liu DD
J Pharm Sci; 1996 Apr; 85(4):415-8. PubMed ID: 8901080
[TBL] [Abstract][Full Text] [Related]
6. Aqueous humor penetration of ketorolac formulated in DuraSite or DuraSite 2 delivery systems compared to Acular LS in rabbits.
Shafiee A; Bowman LM; Hou E; Hosseini K
J Ocul Pharmacol Ther; 2013 Nov; 29(9):812-6. PubMed ID: 23992042
[TBL] [Abstract][Full Text] [Related]
7. Stability indicating HPLC-DAD method for analysis of Ketorolac binary and ternary mixtures in eye drops: Quantitative analysis in rabbit aqueous humor.
El Yazbi FA; Hassan EM; Khamis EF; Ragab MAA; Hamdy MMA
J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Nov; 1068-1069():218-225. PubMed ID: 29080492
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and efficacy of a ketorolac-loaded ocular coil in New Zealand white rabbits.
Bertens CJF; Gijs M; Dias AAJ; van den Biggelaar FJHM; Ghosh A; Sethu S; Nuijts RMMA
Drug Deliv; 2021 Dec; 28(1):400-407. PubMed ID: 33594935
[TBL] [Abstract][Full Text] [Related]
9. Remote temperature monitoring in ocular tissue using confocal Raman spectroscopy.
Bauer NJ; Motamedi M; Hendrikse F; Wicksted JP
J Biomed Opt; 2005; 10(3):031109. PubMed ID: 16229634
[TBL] [Abstract][Full Text] [Related]
10. Penetration of topically applied diclofenac and ketorolac into the aqueous humour and subretinal fluid: randomized clinical trial.
Unlu N; Kocaoglan H; Sayin F; Hazirolan D; Demircan S; Basci N; Acar MA; Demir NM; Duman S
Can J Ophthalmol; 2010 Dec; 45(6):610-5. PubMed ID: 20935692
[TBL] [Abstract][Full Text] [Related]
11. Aqueous prostaglandin E(2) of cataract patients at trough ketorolac and bromfenac levels after 2 days dosing.
Bucci FA; Waterbury LD
Adv Ther; 2009 Jun; 26(6):645-50. PubMed ID: 19568702
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of 0.4% ketorolac tromethamine ophthalmic solution versus 0.5% ketorolac tromethamine ophthalmic solution after phacoemulsification and intraocular lens implantation.
Sandoval HP; De Castro LE; Vroman DT; Solomon KD
J Ocul Pharmacol Ther; 2006 Aug; 22(4):251-7. PubMed ID: 16910866
[TBL] [Abstract][Full Text] [Related]
13. Comparison of cyclooxygenase inhibitory activity and ocular anti-inflammatory effects of ketorolac tromethamine and bromfenac sodium.
Waterbury LD; Silliman D; Jolas T
Curr Med Res Opin; 2006 Jun; 22(6):1133-40. PubMed ID: 16846546
[TBL] [Abstract][Full Text] [Related]
14. Intraocular penetration of periocular ketorolac and efficacy in experimental uveitis.
Rabiah PK; Fiscella RG; Tessler HH
Invest Ophthalmol Vis Sci; 1996 Mar; 37(4):613-8. PubMed ID: 8595961
[TBL] [Abstract][Full Text] [Related]
15. An update on the use of ophthalmic ketorolac tromethamine 0.4%.
Perry HD; Donnenfeld ED
Expert Opin Pharmacother; 2006 Jan; 7(1):99-107. PubMed ID: 16370927
[TBL] [Abstract][Full Text] [Related]
16. Ketoroloac tromethamine loaded nanodispersion incorporated into thermosensitive in situ gel for prolonged ocular delivery.
Morsi N; Ghorab D; Refai H; Teba H
Int J Pharm; 2016 Jun; 506(1-2):57-67. PubMed ID: 27091293
[TBL] [Abstract][Full Text] [Related]
17. Reduction of interleukin 8 and platelet-derived growth factor levels by topical ketorolac, 0.45%, in patients with diabetic retinopathy.
Schoenberger SD; Kim SJ; Shah R; Sheng J; Cherney E
JAMA Ophthalmol; 2014 Jan; 132(1):32-7. PubMed ID: 24336915
[TBL] [Abstract][Full Text] [Related]
18. The quantitative effect of 0.5% ketorolac tromethamine solution and 0.1% dexamethasone sodium phosphate solution on postsurgical blood-aqueous barrier.
Flach AJ; Kraff MC; Sanders DR; Tanenbaum L
Arch Ophthalmol; 1988 Apr; 106(4):480-3. PubMed ID: 3355415
[TBL] [Abstract][Full Text] [Related]
19. Nanodispersion-loaded mucoadhesive polymeric inserts for prolonged treatment of post-operative ocular inflammation.
Morsi N; Ghorab D; Refai H; Teba H
J Microencapsul; 2017 May; 34(3):280-292. PubMed ID: 28420308
[TBL] [Abstract][Full Text] [Related]
20. The analgesic and anti-inflammatory profile of ketorolac and its tromethamine salt.
Rooks WH; Maloney PJ; Shott LD; Schuler ME; Sevelius H; Strosberg AM; Tanenbaum L; Tomolonis AJ; Wallach MB; Waterbury D
Drugs Exp Clin Res; 1985; 11(8):479-92. PubMed ID: 3879752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
